| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +4,520,260 | 70% | $18.18 | +$82,199,970 |
| Sells | 6 | -1,936,264 | 30% | $38.53 | -$74,611,986 |
| Net | -2 | +2,583,996 | 40% | +$7,587,984 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Brian Taylor Slingsby | Director, 10%+ Owner | $342,631,377 | -$39,850,004 | -10% | 20 Nov 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | $139,141,285 | +$47,499,981 | +52% | 04 Sep 2025 |
| SRINIVAS AKKARAJU | Director | $101,372,213 | +$23,099,993 | +30% | 04 Sep 2025 |
| Samsara BioCapital GP, LLC | 10%+ Owner | $76,611,366 | +$8,100,000 | +12% | 13 Mar 2025 |
| HBM Healthcare Investments (Cayman) Ltd. | 10%+ Owner | $19,199,542 | 14 Feb 2023 | ||
| David Malcom Rodman | Chief Medical Officer | $2,195,624 | -$11,403,774 | -84% | 02 Jan 2026 |
| Adam Levy | CFO and Secretary | $909,377 | -$7,276,179 | -89% | 11 Nov 2025 |
| Jon Congleton | Chief Executive Officer, Director | $353,908 | -$10,316,142 | -97% | 21 Nov 2025 |
| Alexander M. Gold | Director | $0 | -$1,576,095 | -100% | 11 Nov 2025 |
| Daphne Karydas | Director | $0 | -$689,797 | -100% | 13 Nov 2025 |
| Alexander Asam | Director | 09 Feb 2023 | |||
| Takeshi Takahashi | Director | 12 Jul 2023 | |||
| Olivier Litzka | Director | 22 May 2024 | |||
| Derek DiRocco | Director | 13 Feb 2025 | |||
| GLENN SBLENDORIO | Director | 13 Feb 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|